HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T-cadherin loss promotes experimental metastasis of squamous cell carcinoma.

Abstract
T-cadherin is gaining recognition as a determinant for the development of incipient invasive squamous cell carcinoma (SCC). However, effects of T-cadherin expression on the metastatic potential of SCC have not been studied. Here, using a murine model of experimental metastasis following tail vein injection of A431 SCC cells we report that loss of T-cadherin increased both the incidence and rate of appearance of lung metastases. T-cadherin-silenced SCC metastases were highly disordered with evidence of single cell dissemination away from main foci whereas SCC metastases overexpressing T-cadherin developed as compact, tightly organised sheets. SCC cell adhesion to vascular endothelial cells (EC) in culture was increased for T-cadherin-silenced SCC and decreased for T-cadherin-overexpressing SCC. Confocal microscopy showed that T-cadherin-silenced SCC adherent on EC display an elongated morphology with long thin extensions and a high degree of intercalation within the EC monolayer, whereas SCC overexpressing T-cadherin formed poorly-spread multicellular aggregates that remain on the outer surface of the EC monolayer. T-cadherin-deficient SCC or human keratinocyte cells exhibited increased transendothelial migration in vitro which could be attenuated in the presence of EGFR inhibitor gefitinib. Our data suggest that loss of T-cadherin can increase metastatic potential and aggressiveness of SCC, possibly due to facilitating arrest and extravasation through the vascular wall and/or more efficient establishment of metastases in the new microenvironment.
AuthorsMaria Philippova, Dennis Pfaff, Emmanouil Kyriakakis, Stanislaw A Buechner, Giandomenica Iezzi, Giulio C Spagnoli, Andreas W Schoenenberger, Paul Erne, Therese J Resink
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 49 Issue 8 Pg. 2048-58 (May 2013) ISSN: 1879-0852 [Electronic] England
PMID23369463 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Cadherins
  • H-cadherin
  • Protein Kinase Inhibitors
  • Quinazolines
  • ErbB Receptors
  • Gefitinib
Topics
  • Animals
  • Cadherins (genetics, metabolism)
  • Carcinoma, Squamous Cell (genetics, metabolism, pathology)
  • Cell Adhesion (genetics)
  • Cell Line, Tumor
  • Cells, Cultured
  • Coculture Techniques
  • Endothelial Cells (cytology, metabolism)
  • ErbB Receptors (antagonists & inhibitors, metabolism)
  • Gefitinib
  • Human Umbilical Vein Endothelial Cells (cytology, metabolism)
  • Humans
  • Immunoblotting
  • Keratinocytes (cytology, metabolism)
  • Lung Neoplasms (genetics, metabolism, secondary)
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Microscopy, Confocal
  • Neoplasms, Experimental (genetics, metabolism, pathology)
  • Protein Kinase Inhibitors (pharmacology)
  • Quinazolines (pharmacology)
  • RNA Interference
  • Skin Neoplasms (genetics, metabolism, pathology)
  • Transendothelial and Transepithelial Migration (drug effects, genetics)
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: